Merck & Co., Inc. MRK
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.45B | 3.17B | 8.94B | 18.25B | 19.03B |
| Total Depreciation and Amortization | 5.80B | 5.39B | 4.98B | 4.64B | 4.33B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.89B | 13.60B | 8.85B | 556.00M | 209.00M |
| Change in Net Operating Assets | -3.44B | -2.20B | -4.88B | -6.98B | -6.51B |
| Cash from Operations | 18.70B | 19.97B | 17.89B | 16.47B | 17.07B |
| Capital Expenditure | -3.96B | -3.90B | -3.78B | -4.11B | -4.02B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -25.29B | -24.66B | -18.82B | -10.04B | -2.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 918.00M | 1.27B | 132.00M | 413.00M | 34.00M |
| Cash from Investing | -28.33B | -27.30B | -22.46B | -13.74B | -3.98B |
| Total Debt Issued | 19.81B | 25.77B | 14.88B | 13.82B | 5.96B |
| Total Debt Repaid | -7.15B | -7.15B | -1.14B | -2.50B | -3.04B |
| Issuance of Common Stock | 494.00M | 261.00M | 230.00M | 92.00M | 57.00M |
| Repurchase of Common Stock | -3.54B | -4.21B | -4.79B | -5.08B | -4.32B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.37B | -8.30B | -8.23B | -8.18B | -8.11B |
| Other Financing Activities | -156.00M | -212.00M | -88.00M | -68.00M | -231.00M |
| Cash from Financing | 1.10B | 6.17B | 852.00M | -1.92B | -9.68B |
| Foreign Exchange rate Adjustments | -79.00M | -23.00M | 388.00M | 563.00M | 173.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.61B | -1.18B | -3.33B | 1.37B | 3.57B |